We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Phase II study of the halichondrin B analog eribulin mesylate in patients with locally advanced or metastatic breast cancer previously treated with an anthracycline, a taxane, and capecitabine.
- Authors
Cortes, Javier; Vahdat, Linda; Blum, Joanne L; Twelves, Chris; Campone, Mario; Roché, Henri; Bachelot, Thomas; Awada, Ahmad; Paridaens, Robert; Goncalves, Anthony; Shuster, Dale E; Wanders, Jantien; Fang, Fang; Gurnani, Renuka; Richmond, Elaine; Cole, Patricia E; Ashworth, Simon; Allison, Mary Ann
- Abstract
The activity and safety of eribulin mesylate (E7389), a nontaxane microtubule dynamics inhibitor with a novel mechanism of action, were evaluated in patients with locally advanced or metastatic breast cancer previously treated with an anthracycline, taxane, and capecitabine.
- Publication
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2010, Vol 28, Issue 25, p3922
- ISSN
1527-7755
- Publication type
Journal Article
- DOI
10.1200/JCO.2009.25.8467